Vaccine is a recombinant poxviral compound. One patient with metastatic breast cancer had a sustained complete response. PHILADELPHIA — Treatment with a recombinant poxviral vaccine showed a positive response in both metastatic breast cancer and...
Filed under: Press Releases, Treatment, Breast Cancer, Cancer, Media Materials, AACR, American Association for Cancer Research, Clinical Cancer Research, women, ovarian cancer, journal, National Cancer Institute, NCI, Vaccine, Metastatic, therapeutic vaccine, Dr. James Gulley, complete response, cancer vaccine